You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

LOXITANE IM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Loxitane Im, and when can generic versions of Loxitane Im launch?

Loxitane Im is a drug marketed by Actavis Labs Ut Inc and is included in one NDA.

The generic ingredient in LOXITANE IM is loxapine hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the loxapine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LOXITANE IM?
  • What are the global sales for LOXITANE IM?
  • What is Average Wholesale Price for LOXITANE IM?
Summary for LOXITANE IM
Drug patent expirations by year for LOXITANE IM
Recent Clinical Trials for LOXITANE IM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mylan PharmaceuticalsPhase 1

See all LOXITANE IM clinical trials

US Patents and Regulatory Information for LOXITANE IM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc LOXITANE IM loxapine hydrochloride INJECTABLE;INJECTION 018039-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for LOXITANE IM

See the table below for patents covering LOXITANE IM around the world.

Country Patent Number Title Estimated Expiration
Brazil 6457122 ⤷  Sign Up
Switzerland 450422 Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine ⤷  Sign Up
Switzerland 485765 Verfahren zur Herstellung basisch substituierter Heterocyclen ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for LOXITANE IM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1389098 300609 Netherlands ⤷  Sign Up PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
1389098 2013C/054 Belgium ⤷  Sign Up PRODUCT NAME: LOXAPINE; AUTHORISATION NUMBER AND DATE: EU/1/13/823/001 20130225
1389098 C300609 Netherlands ⤷  Sign Up PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.